ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

China medical investor Alwin Capital closes fund at $300m

Firm specializes in life science investments such as medical robots, equipment

Founded in 2015, Alwin Capital invests in life science companies and has secured the final close of a dual-currency fund.

HONG KONG -- Chinese venture capital firm Alwin Capital said it has secured the final close of a dual-currency fund at $300 million to invest in life and interdisciplinary sciences.

The yuan investors in the dual-currency fund include large funds of funds, Chinese government guidance funds, medical industry and insurance companies, banks and other financial institutions in China, the company said in a statement without divulging names.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more